BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23526365)

  • 21. Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1α in cancer cells.
    Zhu S; Zhou Y; Wang L; Zhang J; Wu H; Xiong J; Zhang J; Tian Y; Wang C; Wu H
    Mol Carcinog; 2011 Oct; 50(10):770-80. PubMed ID: 21751260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of hypoxia inducible factor-1alpha on cervical cancer cell line HeLa in vitro].
    Cheng YX; Pu DM; Liu R; Li T; Yin L; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):551-4. PubMed ID: 17983496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
    Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
    World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
    Fan H; Li J; Wang J; Hu Z
    Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of HIF-1α in the hypoxia inducible expression of the thiamine transporter, SLC19A3.
    Zera K; Sweet R; Zastre J
    Gene; 2016 Dec; 595(2):212-220. PubMed ID: 27743994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
    Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
    J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
    Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.
    Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H
    Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
    Bai H; Ge S; Lu J; Qian G; Xu R
    J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
    Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
    J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.
    Ohnishi S; Maehara O; Nakagawa K; Kameya A; Otaki K; Fujita H; Higashi R; Takagi K; Asaka M; Sakamoto N; Kobayashi M; Takeda H
    PLoS One; 2013; 8(6):e66255. PubMed ID: 23840432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.
    Du A; Jiang Y; Fan C
    Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer.
    Ma J; Mi C; Wang KS; Lee JJ; Jin X
    Oncotarget; 2016 Jun; 7(24):36551-36562. PubMed ID: 27144516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.
    Yi T; Papadopoulos E; Hagner PR; Wagner G
    J Biol Chem; 2013 Jun; 288(26):18732-42. PubMed ID: 23667251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
    Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
    Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.